BSE filing, NSE: NITCO. Summary written from the filing by ALFA Finder's alert engine.
Nitco Ltd: key numbers
- Share price
- ₹69.44
- Market cap
- ₹1,754 Cr
- Revenue (annual)
- ₹542.0 Cr
- Net profit (annual)
- ₹28.90 Cr
- P/E (TTM)
- -60.7×Sector 41.7×
- Promoter holding
- 23.96%+3.79% QoQ
- FII holding
- 2.09%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Nitco Ltd
All →Nitco Board Meeting Date
NITCO Limited will hold a board meeting on 03 Nov 2026 to consider unaudited standalone and consolidated half-yearly results for the period ended September 2026. Trading window is closed from 01 Oct to 05 Nov 2026.
Nitco Merger & Restructuring Worth ₹143 Cr
Nitco Ltd completed the conveyance deed for 75% of its Kanjurmarg land, receiving ₹143 crore. The company expects ₹250 crore revenue from future commercial space sales.
- Value
- ₹143.0 Cr
- From
- R Siddhatva Developers Private Limited
Nitco Annual General Meeting
Nitco Ltd held its 60th Annual General Meeting on September 17, 2026, through video conferencing. Shareholders considered resolutions including financial statements, director re-appointment, and related party transactions.
Nitco Management Change
NITCO Limited appointed Mr. Arihant Kothari as Company Secretary and Compliance Officer, effective September 15, 2026. This follows the board's decision to strengthen governance and management.
Nitco Board Meeting Outcome
Nitco Ltd's Board appointed Mr. Arihant Kothari as Company Secretary, Compliance Officer, KMP, and Senior Management Personnel effective September 15, 2026. No financial transaction or monetary value is involved.
Nitco Credit Rating
Nitco Limited received a credit rating reaffirmation for its Non-Convertible Debentures and Redeemable Non-Convertible Preference Shares, totaling ₹200 Crore.
- Value
- ₹200.0 Cr
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.